Sex-Specific Genomic Biomarkers for Individualized Treatment of Life-Threatening Diseases

Table 3

Melanoma training dataset distribution.

Melanoma training set
Gender (class)	Clinical endpoint (abbrev., class)		Total patients	Final gene; count
	High survival and small tumor size; (HS/ST, “0”)	Low survival and nonsmall tumor size; (LS/NST, “1”)
Male (“0”)	12	15	27	4641
Female (“1”)	30	26	56
Total	42	41	83